ACOX3 antibody
Principal name
ACOX3 antibody
Alternative names for ACOX3 antibody
BRCOX, PRCOX, BRCACox, Pristanoyl-CoA oxidase, Peroxisomal acyl-coenzyme A oxidase 3, Branched-chain acyl-CoA oxidase
Ncbi ID
9606, NM_003501, NP_001095137.1, AAH17053.1, NP_003492, NM_030721, NM_053339, NP_109646.2
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), Paraffin Sections (P), Enzyme Immunoassay (E)
Background of ACOX3 antibody
- Kit Component:
- - KN300742G1, Acox3 gRNA vector 1 in pCas-Guide vector
- KN300742G2, Acox3 gRNA vector 2 in pCas-Guide vector
- KN300742D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Human 721_B; WB Suggested Anti-ACOX3 Antibody. . Titration: 1.0 ug/ml. . Positive Control: 721_B Whole Cell. ACOX3 is strongly supported by BioGPS gene expression data to be expressed in Human 721_B cells.; ACOX3 antibody - C-terminal region (ARP60790_P050) in Human 721_B cells using Western Blot
Sample (30 ug of whole cell lysate). A: A549. 7.5% SDS PAGE. TA308019 diluted at 1:1000.
ACOX3 antibody detects ACOX3 protein by Western blot analysis. A. 50 ug mouse liver lysate/extract. 7.5 % SDS-PAGE. ACOX3 antibody (TA308019) dilution: 1:500
Immunohistochemical analysis of paraffin-embedded H441 xenograft, using ACOX3(TA308019) antibody at 1:500 dilution.
Predicted cell location: Cytoplasm. Positive control: Human cervical and lung cancer tissue. Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded human cervical cancer tissue using ACOX3 antibody at dilution 1/25, on the right is treated with the fusion protein. (Original magnification:x 200)
Predicted cell location: Cytoplasm. Positive control: Human cervical and lung cancer tissue. Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded human lung cancer tissue using ACOX3 antibody at dilution 1/25, on the right is treated with the fusion protein. (Original magnification:x200)
Predicted cell location: Cytoplasm. Positive control: Human cervical and colon cancer tissue. Recommended dilution: 1/50-200 The image on the left is immunohistochemistry of paraffin-embedded human cervical cancer tissue using ACOX3 antibody at dilution 1/35, on the right is treated with the fusion protein. (Original magnification:x 200)
Predicted cell location: Cytoplasm. Positive control: Human cervical and colon cancer tissue. Recommended dilution: 1/50-200 The image on the left is immunohistochemistry of paraffin-embedded human colon cancer tissue using ACOX3 antibody at dilution 1/35, on the right is treated with the fusion protein. (Original magnification:x200)
WB Suggested Anti-ACOX3 Antibody; Titration: 1.0 ug/ml; Positive Control: 721_B Whole Cell ACOX3 is strongly supported by BioGPS gene expression data to be expressed in Human 721_B cells
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA308019 | ACOX3 antibody |
||||||
| Rabbit Polyclonal antibody to ACOX3 (acyl-Coenzyme A oxidase 3, pristanoyl) | |||||||
 |
Rabbit | IgG | Aff - Purified | Hu, Ms | P, WB |
0.1 ml /
€415.00
|
|
| OriGene Technologies, Inc. | |||||||
 +2 additional images |
|||||||
| TA323247 | ACOX3 antibody |
||||||
| Anti-ACOX3 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA323248 | ACOX3 antibody |
||||||
| Anti-ACOX3 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP322515 | ACOX3 (transcript variant 1) |
||||
| Recombinant protein of human acyl-Coenzyme A oxidase 3, pristanoyl (ACOX3), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY401181 | ACOX3 overexpression lysate |
|
 |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR210128L2V | Lenti ORF particles, Acox3 (GFP-tagged) - Mouse acyl-Coenzyme A oxidase 3, pristanoyl (Acox3), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,460.00
|
|
| OriGene Technologies, Inc. | ||
| MR210128L1V | Lenti ORF particles, Acox3 (Myc-DDK-tagged) - Mouse acyl-Coenzyme A oxidase 3, pristanoyl (Acox3), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,320.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR212806L2V | Lenti ORF particles, Acox3 (GFP-tagged ORF) - Rat acyl-Coenzyme A oxidase 3, pristanoyl (Acox3), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,460.00
|
|
| OriGene Technologies, Inc. | ||
| RR212806L1V | Lenti ORF particles, Acox3 (Myc-DDK-tagged ORF) - Rat acyl-Coenzyme A oxidase 3, pristanoyl (Acox3), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,320.00
|
|
| OriGene Technologies, Inc. | ||